RAYMOND JAMES & ASSOCIATES - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 74 filers reported holding CORMEDIX INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CORMEDIX INC
ValueSharesWeighting
Q3 2023$137,000
-6.2%
37,027
+0.5%
0.00%
Q2 2023$146,019
+1.3%
36,827
+5.7%
0.00%
Q1 2023$144,184
+1.6%
34,827
+3.6%
0.00%
Q4 2022$141,906
+49.4%
33,6270.0%0.00%
Q3 2022$95,000
-29.6%
33,6270.0%0.00%
Q2 2022$135,000
-26.6%
33,6270.0%0.00%
Q1 2022$184,000
+11.5%
33,627
-7.2%
0.00%
Q4 2021$165,000
+9.3%
36,226
+11.8%
0.00%
Q3 2021$151,000
+3.4%
32,411
+52.4%
0.00%
Q2 2021$146,000
-39.4%
21,274
-11.7%
0.00%
Q1 2021$241,000
+46.1%
24,099
+8.6%
0.00%
Q4 2020$165,000
+23.1%
22,2000.0%0.00%
Q3 2020$134,000
+109.4%
22,200
+119.5%
0.00%
Q2 2020$64,000
+68.4%
10,113
-3.3%
0.00%
Q1 2020$38,00010,4530.00%
Other shareholders
CORMEDIX INC shareholders Q3 2020
NameSharesValueWeighting ↓
Spinnaker Capital LLC 175,384$705,000100.00%
Wick Capital Partners, LLC 114,697$461,0000.32%
PLANNING DIRECTIONS INC 50,000$201,0000.15%
Elliott Investment Management L.P. 1,550,523$6,233,0000.07%
NOMURA HOLDINGS INC 5,904,254$22,806,0000.04%
Ergoteles LLC 183,300$737,0000.02%
XTX Topco Ltd 12,100$49,0000.02%
RIVERSEDGE ADVISORS, LLC 11,373$46,0000.02%
Cresset Asset Management, LLC 329,796$1,326,0000.02%
PDT Partners, LLC 41,623$167,0000.02%
View complete list of CORMEDIX INC shareholders